Treatment method capable of killing viruses in in vitro blood and device for treatment method

Abstract

The invention discloses a treatment method capable of killing viruses in in vitro blood. By arranging a a lead sealed box which integrates functions of X-ray irradiation, halogen lamp light irradiation and X-ray radiation shielding and is internally provided with an irradiation cavity, an in vitro blood sample with a methylene blue photosensitizer is subjected to a method of X-ray irradiation andhalogen light irradiation in the irradiation cavity at the same time, and the viruses, bacteria and lymphocytes with the immunological activity in the blood are killed. The invention further disclosesa device capable of killing the viruses in the in vitro blood. For the treatment method and the device disclosed by the invention, as two existing step-by-step single treatment processes are finishedat the same time by being integrated in one lead box body, the treatment space is greatly compressed, the treatment time is shortened, the treatment quality and the working efficiency are improved, equipment is further simplified, repeated packaging, round-trip transportation and sample between-group errors of the blood sample are omitted, ensurrance of the consistency of treatment results is facilitated, and thus the defects existing in the aspect of singly treating the in vitro blood step by step at present are effectively overcome.

Description

technical field [0001] The invention relates to the technical field of blood treatment, in particular to a treatment method capable of killing viruses in isolated blood and a device thereof. Background technique [0002] In the medical field, for the isolated blood collected from the human body, it is necessary to kill the viruses that may infect hepatitis B and AIDS in the blood before transfusion to the patient, and the killing may cause "transfusion-related graft resistance." Treatment of immunocompetent lymphocytes for "host disease" to reduce transfusion reactions and improve transfusion safety. "Transfusion-associated graft-versus-host disease" is one of the most serious rejection reactions that may be caused by the human body after blood transfusion. Although the incidence rate is less than 1%, there is no specific treatment, and the mortality rate is as high as 90%. The current effective method of prevention is to irradiate the blood with X-rays to kill the immune-a...

AI Technical Summary

Problems solved by technology

[0003] The purpose of the present invention is to provide a treatment method and device capable of killing viruses in isolated blood, so as to overcome the shortcomings of the existing step-by-step single treatment of isolated blood, and to facilitate high-efficiency, high-quality, and low-cost Completely kill the virus and immunocompetent lymphocytes in the isolated blood